Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

Struggling gene-sequencing machine and chemical company Illumina (ILMN) has fallen further into the hands of activist investors. Keith ...

Illumina Inc. added activist investor Keith Meister to its board and elevated director Scott Gottlieb, a former head of the ...

Illumina (ILMN) stock rises as activist investor Keith Meister joins the board, with Scott Gottlieb named chairman. Read more ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina, and current board member Scott ...

Keith Meister’s hedge fund Corvex Management has a 2.5% stake in the gene-sequencing machine maker.

The global life science and chemical instruments market is set to witness remarkable expansion, reaching an estimated value of USD 47.5 billion in 2024. With a steady compound annual growth rate (CAGR ...

To test these hypotheses, we used high-throughput Illumina MiSeq sequencing to assess AMF communities across treatments. The findings of this study will provide critical insights into how root ...

Illumina has established a strong foothold in the market. The company’s product portfolio includes high-throughput sequencers like the NovaSeq X series, as well as lower-throughput instruments such as ...

To address this gap, fecal samples were collected from both GZH and WH, and 16S rRNA high-throughput sequencing was utilized to analyze the differences in their gut microbiota. The results indicated ...

Earlier this month—after the White House added an additional 10% duty on China, alongside planned 25% tariffs on Canada and Mexico—the country barred Illumina’s shipments of DNA sequencers ...